Federal: HR8596

Bill Summary

HR 8596, the Fair and Accurate Ingredient Representation on Labels Act of 2026, mandates clear labeling requirements for cell-cultivated protein products and plant-based alternative proteins. The bill requires cell-cultivated products to be labeled as "cell-cultivated" with a disclaimer that they are not naturally produced from live animals, and requires plant-based alternatives to be labeled as such and clearly identified as non-animal derived. It establishes regulatory oversight with the Secretary of Agriculture implementing labeling standards and the Secretary of Health and Human Services handling pre-market reviews, cell bank oversight, and facility inspections. The bill requires the USDA and HHS to revise their existing regulatory agreement and establish common standards of identity for both product categories within 180 days of enactment.

Why It Matters to MAHA

MAHA supports HR 8596 because it advances transparency in food labeling and consumer autonomy by ensuring Americans can make fully informed purchasing decisions about the protein products they buy. The bill does not ban or restrict any legitimate food products but instead requires honest, accurate labeling that distinguishes between traditionally-produced meat and poultry versus cell-cultivated and plant-based alternatives. This approach respects patient and consumer freedom to choose among available options based on complete ingredient and sourcing information. Clear labeling standards also reduce consumer confusion and strengthen trust in the food system by preventing misleading marketing claims.